小方制药 (603207)

Shanghai Xiao Fang Pharmaceutical Co., Ltd.

ASH

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 16056.00
  • Circulating A-Shares(W): 5440.00
  • Earnings Per Share(RMB): 1.0600
  • Net Assets Per Share(RMB): 6.5651
  • Operating Revenue(W RMB): 39721.86
  • Total Profit(W RMB): 19831.73
  • **Net Profit Attributable to Parent(W RMB) **: 16989.40
  • Net Profit Growth Rate(%): 5.09
  • Weighted Return on Equity(%): 14.1500
  • Operating Cash Flow Per Share(RMB): 0.8340
  • Undistributed Profit Per Share(RMB): 2.1769
  • Capital Reserve Per Share(RMB): 3.0395

2. Main Business

The main business covers:

  • Research, development, production, and sales of external medicines

3. Company Basic Information

  • Company Name: Shanghai Xiaofang Pharmaceutical Co., Ltd.
  • Listing Date: 2024-08-26
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 777 Hongzhu Road, Fengxian District, Shanghai
  • Website: https://www.xf-pharma.com
  • Company Profile: The company was established through the overall change of Yunjia Co., Ltd. into a joint stock company, with the audited net assets as of August 31, 2021, converted into shares. The industrial and commercial change registration was completed on December 24, 2021. It is mainly engaged in the research, development, production, and sales of external medicines.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Shandong New Era Private Fund Management Co., Ltd. - Shandong Province New Kinetic Energy Linghang Medical Care Equity Investment Fund Partnership (Limited Partnership) General Legal Person 240.00 4.41
2 Laobaixing Pharmaceutical Group Co., Ltd. General Legal Person 156.39 2.87
3 Guoxin Capital Co., Ltd. General Legal Person 97.00 1.78
4 China Foreign Economic and Trade Trust Co., Ltd. - Foreign Trade Trust - Renqiao Zeyuan Stock Private Securities Investment Fund Private Securities Investment Fund 80.84 1.49
5 GF Duoyuan Emerging Stock Securities Investment Fund Fund 75.31 1.38
6 China National Petroleum Corporation Enterprise Annuity Plan - Industrial and Commercial Bank of China Co., Ltd. Annuity 67.94 1.25

5. Concept Sectors

  • Medical Aesthetics Concept
  • Innovative Drugs
  • Margin Trading & Securities Lending
  • High-Performance Stocks
  • High Dividend Stocks
  • Stocks Listed Within Two Years

Remarks

  • Data update date: 2025-09-30
  • Data source: Public Market Information